- Home
- AMBO vs BFRI Comparison
AMBO vs BFRI Comparison
Compare AMBO & BFRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMBO
- BFRI
- Stock Information
- Founded
- AMBO 2000
- BFRI 1997
- Country
- AMBO United States
- BFRI United States
- Employees
- AMBO N/A
- BFRI N/A
- Industry
- AMBO Other Consumer Services
- BFRI Biotechnology: Pharmaceutical Preparations
- Sector
- AMBO Real Estate
- BFRI Health Care
- Exchange
- AMBO Nasdaq
- BFRI Nasdaq
- Market Cap
- AMBO 7.1M
- BFRI 7.5M
- IPO Year
- AMBO 2010
- BFRI 2021
- Fundamental
- Price
- AMBO $2.56
- BFRI $0.83
- Analyst Decision
- AMBO
- BFRI Strong Buy
- Analyst Count
- AMBO 0
- BFRI 1
- Target Price
- AMBO N/A
- BFRI $7.00
- AVG Volume (30 Days)
- AMBO 11.6K
- BFRI 80.1K
- Earning Date
- AMBO 12-30-2024
- BFRI 05-14-2025
- Dividend Yield
- AMBO N/A
- BFRI N/A
- EPS Growth
- AMBO N/A
- BFRI N/A
- EPS
- AMBO 0.11
- BFRI N/A
- Revenue
- AMBO $9,392,000.00
- BFRI $37,321,000.00
- Revenue This Year
- AMBO N/A
- BFRI $18.57
- Revenue Next Year
- AMBO N/A
- BFRI $20.17
- P/E Ratio
- AMBO $23.56
- BFRI N/A
- Revenue Growth
- AMBO 2.50
- BFRI 9.54
- 52 Week Low
- AMBO $1.00
- BFRI $0.65
- 52 Week High
- AMBO $5.55
- BFRI $2.22
- Technical
- Relative Strength Index (RSI)
- AMBO 47.49
- BFRI 48.57
- Support Level
- AMBO $2.45
- BFRI $0.76
- Resistance Level
- AMBO $3.14
- BFRI $0.87
- Average True Range (ATR)
- AMBO 0.30
- BFRI 0.07
- MACD
- AMBO -0.02
- BFRI 0.01
- Stochastic Oscillator
- AMBO 19.86
- BFRI 81.02
About AMBO Ambow Education Holding Ltd.
Ambow Education Holding Ltd is a provider of educational and career enhancement services in China. It operates through CP&CE Programs. The CP&CE Programs include tutoring services and career enhancement services. Geographically all the operations function in the United States and Foreign countries.
About BFRI Biofrontera Inc.
Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy. The Company's licensed products, which include Ameluz as well as the BF-RhodoLED and RhodoLED XL lamps (together, the RhodoLED Lamps), are used for the treatment of actinic keratoses (AKs), which are pre-cancerous skin lesions.